CADM2 and esophageal squamous cell carcinoma: Additionally, when CADM2 is knocked down, the anti-proliferative and pro-apoptotic effects of anti-miR-21-5p are attenuated, highlighting the crucial role of the miR-21-5p/CADM2-Akt pathway in regulating ESCC progression.